MX174093B - 1,1-DIOXIDOS DE 3,4-DIHIDRO-2-ALQUIL-3-OXO-N-ARIL-2H[1] BENZOTIENO[3,2-e]-1,2-TIAZINO-4-CARBOXIAMIDA - Google Patents
1,1-DIOXIDOS DE 3,4-DIHIDRO-2-ALQUIL-3-OXO-N-ARIL-2H[1] BENZOTIENO[3,2-e]-1,2-TIAZINO-4-CARBOXIAMIDAInfo
- Publication number
- MX174093B MX174093B MX011827A MX1182788A MX174093B MX 174093 B MX174093 B MX 174093B MX 011827 A MX011827 A MX 011827A MX 1182788 A MX1182788 A MX 1182788A MX 174093 B MX174093 B MX 174093B
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- dihydro
- oxo
- benzotieno
- carboxiamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Hydrogenated Pyridines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a 1,1-dióxidos de 3,4-dihidro-2-alquil-3-oxo-N-aril-2H-[1]benzotieno[3,2-e] 1,2-tiazino-4-carboxiamida, a metodos de preparación de estos compuestos, a composiciones farmaceuticas que contienen estos compuestos y al uso de dichos compuestos en el tratamiento de la inflamación (v.g., artritis) u otras enfermedades mediadas por prostaglandinas o leucotrienos. Los compuestos de la presente invención son compuestos de fórmula y sus sales farmaceuticamente aceptables.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1987/001357 WO1988009793A1 (en) | 1987-06-10 | 1987-06-10 | 3,4-DIHYDRO-2-ALKYL-3-OXO-N-ARYL-2H-[1]BENZOTHIENO[3,2-e]-1,2-THIAZINE-4-CARBOXAMIDE-1,1-DIOXIDES |
EP88304975A EP0294994B1 (en) | 1987-06-10 | 1988-06-01 | 3-4-Dihydro-2-alkyl-3-oxo-N-aryl-2H-[1]benzothieno[3,2-el]-1,2-thiazine-4-carboxamide-1,1-dioxides |
Publications (2)
Publication Number | Publication Date |
---|---|
MX11827A MX11827A (es) | 1993-04-01 |
MX174093B true MX174093B (es) | 1994-04-21 |
Family
ID=55448100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX011827A MX174093B (es) | 1987-06-10 | 1987-06-10 | 1,1-DIOXIDOS DE 3,4-DIHIDRO-2-ALQUIL-3-OXO-N-ARIL-2H[1] BENZOTIENO[3,2-e]-1,2-TIAZINO-4-CARBOXIAMIDA |
Country Status (28)
Country | Link |
---|---|
US (1) | US4914101A (es) |
EP (1) | EP0294994B1 (es) |
JP (1) | JPH078874B2 (es) |
KR (1) | KR900006758B1 (es) |
CN (1) | CN1019576B (es) |
AT (1) | ATE105561T1 (es) |
AU (1) | AU593743B2 (es) |
CA (1) | CA1300625C (es) |
CZ (1) | CZ281857B6 (es) |
DD (1) | DD281602A5 (es) |
DE (1) | DE3889497T2 (es) |
DK (1) | DK313388A (es) |
EG (1) | EG18525A (es) |
ES (1) | ES2051846T3 (es) |
FI (1) | FI89802C (es) |
HU (1) | HU203762B (es) |
IE (1) | IE63214B1 (es) |
IL (1) | IL86602A (es) |
MX (1) | MX174093B (es) |
MY (1) | MY103572A (es) |
NO (2) | NO176277C (es) |
NZ (1) | NZ224956A (es) |
PH (1) | PH25187A (es) |
PL (1) | PL158994B1 (es) |
PT (1) | PT87678B (es) |
WO (1) | WO1988009793A1 (es) |
YU (1) | YU46767B (es) |
ZA (1) | ZA884115B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0455830B1 (en) * | 1989-11-30 | 1996-06-26 | Nippon Hypox Laboratories Incorporated | Medicine containing thiazine dioxide derivative |
US6340659B1 (en) | 1995-12-13 | 2002-01-22 | The Lubrizol Corporation | Metal salts of lactones as lubricant additives |
JP4250344B2 (ja) | 2001-01-29 | 2009-04-08 | インターナショナル・ビジネス・マシーンズ・コーポレーション | ワークフローシステム、ワークフローサーバ、および記憶媒体 |
US8741299B2 (en) | 2011-06-20 | 2014-06-03 | The Feinstein Institute For Medical Research | Method for treating pathologies associated with hypoxia using MIF inhibitors |
US9666805B2 (en) * | 2014-11-25 | 2017-05-30 | Northwestern University | Bithiophene sulfonamide-based molecular and polymeric semiconductors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3591584A (en) * | 1968-08-27 | 1971-07-06 | Pfizer | Benzothiazine dioxides |
CA1066711A (en) * | 1974-08-26 | 1979-11-20 | Hoffmann-La Roche Limited | Thiophene derivatives |
LU78009A1 (de) * | 1977-08-22 | 1979-05-23 | Hoffmann La Roche | Verfahren zur herstellung von thiazinderivaten |
AU518216B2 (en) * | 1977-09-06 | 1981-09-17 | Hafslund Nycomed Pharma Aktiengesellschaft | Thienothiazine derivatives |
DE2838377A1 (de) * | 1978-09-02 | 1980-03-20 | Thomae Gmbh Dr K | Neue 4-hydroxy-2h eckige klammer auf 1 eckige klammer zu benzothieno eckige klammer auf 2,3-e eckige klammer zu -1,2- thiazin-3-carboxamid-1,1-dioxide sowie deren salze, deren verwendung und verfahren zu ihrer herstellung |
ZA803401B (en) * | 1979-06-13 | 1981-05-27 | Hoffmann La Roche | Thiazine derivatives |
AU5811280A (en) * | 1979-06-13 | 1980-12-18 | F. Hoffmann-La Roche Ag | Thiazine derivatives |
-
1987
- 1987-06-10 HU HU873899A patent/HU203762B/hu not_active IP Right Cessation
- 1987-06-10 US US07/382,161 patent/US4914101A/en not_active Expired - Lifetime
- 1987-06-10 WO PCT/US1987/001357 patent/WO1988009793A1/en active IP Right Grant
- 1987-06-10 MX MX011827A patent/MX174093B/es unknown
-
1988
- 1988-06-01 EP EP88304975A patent/EP0294994B1/en not_active Expired - Lifetime
- 1988-06-01 ES ES88304975T patent/ES2051846T3/es not_active Expired - Lifetime
- 1988-06-01 DE DE3889497T patent/DE3889497T2/de not_active Expired - Fee Related
- 1988-06-01 AT AT8888304975T patent/ATE105561T1/de not_active IP Right Cessation
- 1988-06-02 IL IL86602A patent/IL86602A/xx not_active IP Right Cessation
- 1988-06-06 MY MYPI88000605A patent/MY103572A/en unknown
- 1988-06-06 JP JP13920488A patent/JPH078874B2/ja not_active Expired - Lifetime
- 1988-06-07 CZ CS883925A patent/CZ281857B6/cs not_active IP Right Cessation
- 1988-06-08 PL PL1988272928A patent/PL158994B1/pl unknown
- 1988-06-08 PH PH37029A patent/PH25187A/en unknown
- 1988-06-08 CA CA000568893A patent/CA1300625C/en not_active Expired - Fee Related
- 1988-06-08 DD DD88316546A patent/DD281602A5/de not_active IP Right Cessation
- 1988-06-08 PT PT87678A patent/PT87678B/pt not_active IP Right Cessation
- 1988-06-09 YU YU111988A patent/YU46767B/sh unknown
- 1988-06-09 EG EG32188A patent/EG18525A/xx active
- 1988-06-09 KR KR1019880006909A patent/KR900006758B1/ko not_active IP Right Cessation
- 1988-06-09 CN CN88103539A patent/CN1019576B/zh not_active Expired
- 1988-06-09 IE IE173388A patent/IE63214B1/en not_active IP Right Cessation
- 1988-06-09 AU AU17535/88A patent/AU593743B2/en not_active Ceased
- 1988-06-09 ZA ZA884115A patent/ZA884115B/xx unknown
- 1988-06-09 DK DK313388A patent/DK313388A/da not_active Application Discontinuation
- 1988-06-09 NZ NZ224956A patent/NZ224956A/xx unknown
-
1989
- 1989-02-08 NO NO890531A patent/NO176277C/no unknown
- 1989-02-09 FI FI890620A patent/FI89802C/fi not_active IP Right Cessation
-
1992
- 1992-07-03 NO NO922636A patent/NO922636D0/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8601978A1 (es) | Procedimiento para preparar derivados de isoquinoleina | |
FI954965A0 (fi) | AMPA-antagonisteja ja hoitomenetelmä, jossa niitä käytetään | |
IT1235013B (it) | 1,4-diidropiridine, loro procedimento di preparazione e loro applicazione come medicamenti | |
MX174093B (es) | 1,1-DIOXIDOS DE 3,4-DIHIDRO-2-ALQUIL-3-OXO-N-ARIL-2H[1] BENZOTIENO[3,2-e]-1,2-TIAZINO-4-CARBOXIAMIDA | |
IT1140847B (it) | Tiazoliliden osso propionitrili, mezzi insetticidi contenenti questi composti e processo per la loro preparazione | |
ES2141096T3 (es) | Compuestos de cefalosporina y composiciones farmaceuticas de los mismos. | |
DK0461574T3 (da) | Lægemidler indeholdende 3,7-diazabicyclo(3,3,1)-nonanforbindelser | |
AU538882B2 (en) | 2,3-dihydro-imidazo(1,2-g)pyridazine derivatives | |
HUT63836A (en) | Process for producing acridine derivatives | |
SE9003704L (sv) | Nya selenofenderivat, ett framstaellningsfoerfarande foer desamma samt terapeutiska kompositioner innehaallande dem | |
ES8609254A1 (es) | Un procedimiento para preparar un derivado de piridinodicar-boxilato |